Skip to content

Cerus CERS Net Change in Cash

Net Change in Cash at other companies

CorMedix logo
CorMedixCRMD
$33.25M+29.7%
Haemonetics logo
HaemoneticsHAE
-$117.93M
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$23.2M-170%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$65.32M+54.0%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$29.4M-202%
ADMA Biologics logo
ADMA BiologicsADMA
$50.52M+260%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's net change in cash?
Cerus (CERS) reported net change in cash of $7.88M in Q1 2026.
How has Cerus's net change in cash changed year-over-year?
Cerus's net change in cash increased by 1115.6% year-over-year, from -$776K to $7.88M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.